Our Partners
BC Cancer
BC Cancer, previously The British Columbia Cancer Agency (BCCA), provides a province-wide, population-based cancer control program for the 4.2 million residents of British Columbia and the Yukon. The Agency’s mandate covers the spectrum of cancer care from prevention and screening, to diagnosis, treatment, through to rehabilitation. BC Cancer has a three-fold mission to: reduce the incidence of cancer; reduce the mortality rate of people with cancer; and improve the quality of life of people living with cancer. The Agency is committed to addressing the challenges posed by cancer control through the application of scientific principles and an established research program that encompasses basic and applied research.
Ontario Health – Cancer Care Ontario
Ontario Health – Cancer Care Ontario (OH-CCO) plays an important role in equipping health professionals, organizations and policy-makers with the most up-to-date cancer knowledge and tools to prevent cancer and deliver high quality patient care. It does this by collecting and analyzing data about cancer services and combining it with evidence and research that is shared with the healthcare community in the form of guidelines and standards. It also monitors and measures the performance of the cancer system, and oversees a funding and governance model that ties funding to performance, making healthcare providers more accountable and ensuring value for investments in the system. OH-CCO actively engages people with cancer and their families in the design, delivery and evaluation of Ontario’s cancer system, and works to improve the performance of Ontario’s cancer system by driving quality, accountability, innovation and value.
University of British Columbia
Centre for Health Services and Policy Research
The Centre for Health Services and Policy Research (CHSPR) is based at UBC and specializes in interdisciplinary research into population health and the ways in which health services can best be organized, funded and delivered. The Centre has expertise in health economics, health services research, and health policy analysis. CHSPR is also home to the BC Linked Health Database, a world-class, population-based data resource for applied health services and population health research. Over the past 20 years, CHSPR has built unique core competencies in linking, extracting and securing data in the BCLHD, and makes BCLHD data available for research in the public interest.
University of Toronto
Joint Centre for Bioethics
The Joint Centre for Bioethics (JCB) is hosted by the University of Toronto and was formed in 1995. It is a partnership among the University and fifteen healthcare organizations in the Toronto area. The Centre is a network of over 180 members, approximately 30 of whom work full-time in bioethics, representing the largest multi-disciplinary group of in-hospital bioethicists in Canada. JCB has trained 100 students through its two bioethics graduate programs and has published more than 900 articles and obtained more than $50 million in research grants.
Department for Health Policy, Management and Evaluation
The Department of Health Policy, Management and Evaluation (HPME) is based at the University of Toronto and is a leading source for innovative thinking in health policy, management and evaluation. As a department of the Faculty of Medicine, HPME brings together experts in health policy, organizational management, economics, law, clinical epidemiology, sociology, political science and information technology to address the challenges facing the health care system. HPME is a leader in research that will make the health care system efficient, effective and sustainable.
Toronto Health Economics and Technology Assessment Collaborative
The Toronto Health Economics and Technology Assessment (THETA) Collaborative is a multi-disciplinary research group supporting effective policy decision-making regarding new drugs and health technologies in Ontario. We are based at the University of Toronto. We do this by synthesizing the best scientific evidence on efficacy, effectiveness, costs, and health-related values creating new evidence presenting evidence to decision-makers so that scientific evidence and the public’s values guide policy decisions, and training individuals in the discipline of health technology assessment (HTA).
ICES
ICES (previously the Institute for Clinical Evaluative Sciences) plays a key role in providing unique scientific insights to help policymakers, managers, planners, practitioners and other researchers shape the future direction of the Ontario health care system. The Institute’s evidence-based knowledge and recommendations, profiled in atlases, investigative reports, and peer-reviewed journals, are used to guide decision-making and inform changes in healthcare delivery. Work encompasses the assessment of care delivery, patterns of service utilization and health technologies. Key to the knowledge produced at ICES is the ability to anonymously link population-based health information on an individual patient basis while ensuring the privacy and confidentiality of health information.
Current Oncology
Current Oncology (ISSN 1718-7729) is an international, peer-reviewed, open access journal published online by MDPI (from Volume 28 Issue 1-2021). Established in 1994, the journal represents a multidisciplinary medium for clinical oncologists to report and review progress in the management of this disease. Dr. Shahid Ahmed from the University of Saskatchewan has served as Editor-in-Chief of Current Oncology since June 2023. The journal is supported by an international editorial board consisting of a distinguished team of cancer researchers from major institutes from Canada and around the world (http://www.mdpi.com/journal/curroncol/editors). Articles published in the journal typically contain information that is relevant directly to clinical oncology practice, and have clear potential for application to the current or future practice of cancer medicine.
Current Oncology is indexed by important databases, including SCIE, PubMed, MEDLINE, and Scopus. Current Oncology received an increased Impact Factor for 2023 of 2.8, following an increased CiteScore of 3.3. Current Oncology now ranks in Q2 in the “Oncology” category (157/322) which represents our ranking relative to other journals in the same field. More information about the journal can be accessed at: http://www.mdpi.com/journal/curroncol.
ARCC members enjoy author fee discounts with our affiliated journal, Current Oncology. Email us at arcc@cc-arcc.ca or contact Karen for more info at karen.irwin@mdpi.com.
Our Funder
Canadian Cancer Society
The Canadian Cancer Society is a founding and funding partner of the Canadian Centre for Applied Research in Cancer Control. The Society’s goal with this investment is to stimulate our research capacity in this area to support the ability to conduct innovative modern science in Canada.
The Canadian Cancer Society is a national community-based organization whose mission is the eradication of cancer and the enhancement of the quality of life of people living with cancer. It is the largest national charitable funder of cancer research in Canada.
Connect With Us!